本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

武田制药

15.06
+0.09000.60%
盘后15.060.00000.00%17:32 EDT
成交量:177.56万
成交额:2,675.09万
市值:470.43亿
市盈率:67.09
高:15.13
开:15.09
低:15.04
收:14.97
数据加载中...
2025/06/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/31

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]